TAKHZYRO 300 mg solution for injection in vial
- Name:
TAKHZYRO 300 mg solution for injection in vial
- Company:
Shire Pharmaceuticals Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 21/05/20

Click on this link to Download PDF directly
Shire Pharmaceuticals Ireland Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 4 January 2021 SPC
Reasons for updating
- Change from joint to individual SPCs
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 6 August 2020 SPC
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
From 30 months to 2 years (vial presentation)
Updated on 21 May 2020 SPC
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 2 - Qualitative and quantitative composition
- Change to section 3 - Pharmaceutical form
- Change to section 4.2 - Posology and method of administration
- Change to section 6.3 - Shelf life
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 21 May 2020 PIL
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 6 - what the product contains
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 9 August 2019 PIL
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
Updated on 9 August 2019 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updates to sections 6.5 additional pack sizes and section 8 additional procedure numbers
Updated on 7 January 2019 PIL
Reasons for updating
- New PIL for new product